CSL Limited (ASX:CSL) Downward Trend Still Oversold

CSL Limited (ASX:CSL) Downward Trend Still Oversold

CSL Limited (ASX:CSL) Downward Trend Still Oversold

CSL Limited

Overall, the bias in prices is: Downwards.

Short term: Prices are moving.

Intermediate term: Prices are trending.

Note: this chart shows extraordinary price action to the downside.

By the way, prices are vulnerable to a correction towards 111.44.

The projected upper bound is: 107.95.

The projected lower bound is: 98.64.

The projected closing price is: 103.30.


A black body occurred (because prices closed lower than they opened).
During the past 10 bars, there have been 2 white candles and 8 black candles for a net of 6 black candles. During the past 50 bars, there have been 23 white candles and 26 black candles for a net of 3 black candles.

Three black candles occurred in the last three days. Although these candles were not big enough to create three black crows, the steady downward pattern is bearish.

Momentum Indicators

Momentum is a general term used to describe the speed at which prices move over a given time period. Generally, changes in momentum tend to lead to changes in prices. This expert shows the current values of four popular momentum indicators.

Stochastic Oscillator

One method of interpreting the Stochastic Oscillator is looking for overbought areas (above 80) and oversold areas (below 20). The Stochastic Oscillator is 10.6717. This is an oversold reading. However, a signal is not generated until the Oscillator crosses above 20 The last signal was a buy 9 period(s) ago.

Relative Strength Index (RSI)

The RSI shows overbought (above 70) and oversold (below 30) areas. The current value of the RSI is 27.92. This is where it usually bottoms. The RSI usually forms tops and bottoms before the underlying security. A buy or sell signal is generated when the RSI moves out of an overbought/oversold area. The last signal was a sell 30 period(s) ago.

Commodity Channel Index (CCI)

The CCI shows overbought (above 100) and oversold (below -100) areas. The current value of the CCI is -188.This is an oversold reading. However, a signal isn’t generated until the indicator crosses above -100. The last signal was a buy 10 period(s) ago.


The Moving Average Convergence/Divergence indicator (MACD) gives signals when it crosses its 9 period signal line. The last signal was a sell 25 period(s) ago.

Rex Takasugi – TD Profile

CSL FPO closed down -1.530 at 103.390. Volume was 10% above average (neutral) and Bollinger Bands were 37% wider than normal.

Open High Low Close Volume___
104.000 104.920 103.000 103.390 1,089,199

Technical Outlook
Short Term: Oversold
Intermediate Term: Bearish
Long Term: Bearish

Moving Averages: 10-period 50-period 200-period
Close: 107.64 112.79 107.12
Volatility: 19 26 24
Volume: 949,351 922,439 1,027,106

Short-term traders should pay closer attention to buy/sell arrows while intermediate/long-term traders should place greater emphasis on the Bullish or Bearish trend reflected in the lower ribbon.


CSL FPO is currently 3.5% below its 200-period moving average and is in an downward trend. Volatility is high as compared to the average volatility over the last 10 periods. Our volume indicators reflect moderate flows of volume out of CSL.AX (mildly bearish). Our trend forecasting oscillators are currently bearish on CSL.AX and have had this outlook for the last 14 periods. Our momentum oscillator is currently indicating that CSL.AX is currently in an oversold condition.


CSL Limited is a biopharmaceutical company that researches, develops, manufactures and markets biotherapies to treat and prevent serious and rare medical conditions. The principal activities of the Company include research, development, manufacture, marketing and distribution of biopharmaceutical and allied products. The Company operates through the three segments: CSL Behring, which manufactures and develops plasma therapies (plasma products and recombinants), bioCSL, which manufactures and distributes non-plasma biotherapeutic products, and CSL Intellectual Property, which includes licensing of intellectual property generated by the Company to unrelated third parties. CSL Behring therapies are indicated for treatment of bleeding disorders including, hemophilia and von Willebrand disease, primary and secondary immune deficiencies, hereditary angioedema, neurological disorders and inherited respiratory disease. bioCSL manufactures seasonal and pandemic influenza vaccines.

The following two tabs change content below.
HEFFX has become one of Asia’s leading financial services companies with interests in Publishing, Private Equity, Capital Markets, Mining, Retail, Transport and Agriculture that span every continent of the world. Our clearing partners have unprecedented experience in Equities, Options, Forex and Commodities brokering, banking, physical metals dealing, floor brokering and trading.